Heerspink HJL, et al.. DAPA-CKD Trial Committees and Investigators. Dapagliflozin in patients with chronic kidney disease. N Engl J Med 2020; 383:1436–1446. doi: 10.1056/NEJMoa2024816
Legendre CM, et al.. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 2013; 368:2169–2181. doi: 10.1056/NEJMoa1208981
Vincenti F, et al.. Belatacept and long-term outcomes in kidney transplantation. N Engl J Med 2016; 374:333–343. doi: 10.1056/NEJMoa1506027. Erratum in: N Engl J Med 2016; 374:698.